Supplemental material
Scandinavian Journal of Rheumatology
Volume 53, 2024 - Issue 2
Articles/Brief Reports
Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
C Roseman1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden
https://orcid.org/0000-0003-0567-0874View further author information
https://orcid.org/0000-0003-0567-0874View further author information, JK Wallman1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Swedenhttps://orcid.org/0000-0002-4915-2924View further author information
https://orcid.org/0000-0002-4915-2924View further author information, A Jöud2 Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Lund, Swedenhttps://orcid.org/0000-0001-7192-4911View further author information
https://orcid.org/0000-0001-7192-4911View further author information, MEC Schelin3 Department of Clinical Sciences Lund, Oncology, Lund University, Lund, Sweden;4 Department of Research and Development, Skåne University Hospital, Lund, Sweden;5 The Institute for Palliative Care, Lund University and Region Skåne, Lund, Swedenhttps://orcid.org/0000-0001-5486-7556View further author information
https://orcid.org/0000-0001-5486-7556View further author information, JT Einarsson1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Swedenhttps://orcid.org/0000-0003-3206-7050View further author information
https://orcid.org/0000-0003-3206-7050View further author information, E Lindqvist1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Swedenhttps://orcid.org/0000-0002-9937-6352View further author information
https://orcid.org/0000-0002-9937-6352View further author information, J Lampa6 Karolinska Institute, Department of Medicine Solna, Rheumatology Unit, Center of Molecular Medicine (CMM), Stockholm, Swedenhttps://orcid.org/0000-0002-7856-3968View further author information
https://orcid.org/0000-0002-7856-3968View further author information, MC Kapetanovic1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Swedenhttps://orcid.org/0000-0002-7853-514XView further author information
https://orcid.org/0000-0002-7853-514XView further author information & T Olofsson1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden;3 Department of Clinical Sciences Lund, Oncology, Lund University, Lund, SwedenCorrespondence[email protected]
https://orcid.org/0000-0002-9919-4487View further author information
https://orcid.org/0000-0002-9919-4487View further author information show all